CIM
CHRS icon

CIM Investment Management’s Coherus Oncology CHRS Stock Holding History

CIM Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9,754
Closed -$207K – 295
2016
Q1 		$207K Buy
+9,754
New +$160K 0.09% 258
2015
Q3 		– Sell
-7,277
Closed -$210K – 256
2015
Q2 		$210K Hold
7,277
– – 0.09% 233
2015
Q1 		$223K Buy
+7,277
New +$188K 0.1% 218

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CIM Investment Management's CHRS Position: Q2 2016 in Review

CIM Investment Management sold out of Coherus Oncology (CHRS) in Q2 2016, closing a stake of 9,754 shares — an estimated $207K sold.

CIM Investment Management first reported a position in CHRS in Q1 2015 and held it in 3 quarters. The position peaked at $223K in Q1 2015. 86 funds tracked by Wall St. Rank hold CHRS as of Q2 2016.

  • CIM Investment Management reported no remaining Coherus Oncology position as of Q2 2016 after selling out during the quarter.
  • CIM Investment Management sold 9,754 Coherus Oncology shares in Q2 2016, an estimated $207K.
  • CIM Investment Management first reported a position in Coherus Oncology in Q1 2015 and held it in 3 quarters.
  • CIM Investment Management's Coherus Oncology position peaked at $223K in Q1 2015.
  • 86 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2016.

Based on CIM Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.